FitLife grows through a roll-up strategy and the Irwin deal boosting 2026 revenue and EBITDA with risks and strong upside.
These days, it seems like everywhere you go, someone’s talking about weight loss drugs. With the explosion in popularity of GLP-1 drugs like Ozempic, another industry has popped up, claiming to offer ...